NCT03137082View on ClinicalTrials.gov

Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 12, 2017

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Alcohol Abstinence
Interventions
DRUG

Guanfacine XR 3mgs/daily

Guanfacine 3mg tablet

DRUG

Placebo (for guanfacine)

Sugar pill manufactured to mimic guanfacine tablets

Trial Locations (1)

11794

The Health Sciences Center, Stony Brook

All Listed Sponsors
lead

Stony Brook University

OTHER

NCT03137082 - Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD) | Biotech Hunter | Biotech Hunter